Enliven Therapeutics, Inc. ELVN | $69.89M | 8.45 | 3.97M | +36.92% | +$18.85M | 4.93 | |
Mind Medicine (MindMed) Inc. MNMD | $54.83M | 8.12 | 5.83M | New | +$54.83M | 3.86 | |
| Merus N.V. MRUS | $196.33M | 7.43 | 4.36M | -8.16% | -$17.44M | 13.84 | |
Cogent Biosciences, Inc. COGT | $43.18M | 6.72 | 6.42M | +15.43% | +$5.77M | 3.04 | |
VistaGen Therapeutics, Inc. VTGN | $8.32M | 5.83 | 1.57M | 0% | +$0 | 0.59 | |
| Vera Therapeutics, Inc. VERA | $136.47M | 5.79 | 3.17M | -41.93% | -$98.53M | 9.62 | |
| Celcuity Inc. CELC | $33.61M | 4.98 | 1.56M | -11.33% | -$4.29M | 2.37 | |
| C4 Therapeutics, Inc. CCCC | $27.86M | 4.96 | 3.41M | -10.25% | -$3.18M | 1.96 | |
Spyre Therapeutics, Inc. SYRE | $71.46M | 4.68 | 1.88M | 0% | +$0 | 5.04 | |
| Nkarta, Inc. NKTX | $34.21M | 4.49 | 3.17M | +15.93% | +$4.7M | 2.41 | |
Perspective Therapeutics, Inc. CATX | $25.05M | 3.3 | 21.05M | New | +$25.05M | 1.77 | |
Pharvaris N.V. PHVS | $39.86M | 3.21 | 1.73M | +115.63% | +$21.38M | 2.81 | |
| Adverum Biotechnologies, Inc. ADVM | $9.29M | 3.17 | 657,333 | -93.43% | -$132.11M | 0.66 | |
Third Harmonic Bio, Inc. THRD | $11.8M | 3.05 | 1.25M | +76.88% | +$5.13M | 0.83 | |
| Viridian Therapeutics, Inc. VRDN | $33.88M | 3.03 | 1.93M | +0.55% | +$185,238.29 | 2.39 | |
| ORIC Pharmaceuticals, Inc. ORIC | $27.5M | 2.97 | 2M | New | +$27.5M | 1.94 | |
| Xenon Pharmaceuticals Inc. XENE | $93.32M | 2.87 | 2.17M | 0% | +$0 | 6.58 | |
| Nuvalent, Inc. NUVL | $111.72M | 2.31 | 1.49M | +11.77% | +$11.77M | 7.87 | |
| Cabaletta Bio, Inc. CABA | $18.77M | 2.28 | 1.1M | -42.1% | -$13.65M | 1.32 | |
Helix Acquisition Corp. II Class A Ordinary Shares HLXB | $5.2M | 2.17 | 500,000 | New | +$5.2M | 0.37 | |
Kyverna Therapeutics, Inc. Common Stock KYTX | $22.66M | 2.12 | 912,189 | New | +$22.66M | 1.6 | |
| Kura Oncology, Inc. KURA | $32.53M | 2 | 1.52M | +22.19% | +$5.91M | 2.29 | |
| Arvinas, Inc. ARVN | $52.63M | 1.86 | 1.27M | +27.5% | +$11.35M | 3.71 | |
| Rhythm Pharmaceuticals, Inc. RYTM | $45.5M | 1.72 | 1.05M | -32.26% | -$21.66M | 3.21 | |
| Adicet Bio, Inc. ACET | $3.23M | 1.67 | 1.37M | New | +$3.23M | 0.23 | |
Neurogene Inc. NGNE | $10.18M | 1.54 | 200,000 | New | +$10.18M | 0.72 | |
| Celldex Therapeutics, Inc. CLDX | $36.37M | 1.32 | 866,468 | +23.43% | +$6.9M | 2.56 | |
Autolus Therapeutics plc AUTL | $14.67M | 0.87 | 2.3M | New | +$14.67M | 1.03 | |
| Vaxcyte, Inc. PCVX | $58.75M | 0.79 | 860,000 | -21.82% | -$16.39M | 4.14 | |
| Immunovant, Inc. IMVT | $24.26M | 0.51 | 750,990 | -24.9% | -$8.05M | 1.71 | |
Apogee Therapeutics, Inc. APGE | $19.27M | 0.5 | 290,000 | +16% | +$2.66M | 1.36 | |
| Soleno Therapeutics, Inc. SLNO | $7.26M | 0.49 | 169,533 | -75.78% | -$22.7M | 0.51 | |
| MacroGenics, Inc. MGNX | $4.34M | 0.47 | 295,020 | New | +$4.34M | 0.31 | |
| Syndax Pharmaceuticals, Inc. SNDX | $7.59M | 0.38 | 318,851 | New | +$7.59M | 0.54 | |
DBV Technologies S.A. DBVT | $69,432.00 | 0.05 | 92,687 | 0% | +$0 | 0.01 | |
Abivax SA American Depositary Shares ABVX | $27.1M | <0.01 | 1.9M | 0% | +$0 | 1.91 |